Clinical Trial Update: A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and efficacy of BIOD-123 compared with insulin lispro (Humalog) in individuals with Type 1 Diabetes Mellitus; the study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BIOD-123
• Humalog (insulin lispro)

Snippet

Sponsor: Biodel | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED